Skip to main content

Table 1 m6A modification promote TIE by activating β-catenin signaling pathway

From: Targeting RNA N6-methyladenosine modification: a precise weapon in overcoming tumor immune escape

Regulator

Cancer

Mechanism

Functions

Refs.

METTL3

CRC

Stabilizes Sec62.

Promotes stemness and chemoresistance of CRC cell by activating β-catenin pathway.

[71]

METTL3, METTL14, FTO, ALKBH5

HCC

Stabilizes circRNA-SORE.

Induces sorafenib resistance of HCC by activating β-catenin pathway.

[72]

METTL3

hepatoblastoma

Promotes CTNNB1 stability.

Promotes proliferation and colony-forming ability of hepatoblastoma cell by activating β-catenin pathway.

[73]

METTL3

hepatoblastoma

Promotes β-catenin expression.

Promotes hepatoblastoma cell proliferation, invasion, and migration by activating β-catenin pathway.

[74]

METTL3

melanoma

Promotes UCK2 stability.

Promotes melanoma cell invasion by activating β-catenin pathway.

[75]

METTL3

NPC

Stabilizes Tankyrase.

Promotes NPC cell migration and invasion by activating β-catenin pathway.

[76]

METTL3

EC

Promotes APC degradation.

Promotes aerobic glycolysis, proliferation, and tumor formation in mice by activating β-catenin pathway.

[77]

METTL3

osteosarcoma

Promotes LEF1 stability.

Promotes osteosarcoma cell proliferation, migration, and invasion by activating β-catenin pathway.

[78]

METTL3

NPC

Promotes TRIM11 stability.

Enhances the chemoresistance by activating β-catenin pathway.

[79]

FTO

CC

Upregulates β-catenin.

Promotes chemo-radiotherapy resistance by upregulating β-catenin.

[80]

ALKBH5

glioblastoma

Promotes SOX2 expression.

Promotes glioblastoma cell proliferation, inhibits apoptosis and temozolomide sensitivity by activating β-catenin pathway.

[81]

YTHDF1

GC

Promotes FZD7 translation.

Promotes GC cell proliferation and tumorigenesis via β-catenin pathway.

[82]

YTHDF1

CRC

Promotes TCF7L2/TCF4 translation.

Promotes intestinal stem cell stemness via β-catenin pathway.

[83]

YTHDF1

HCC

Promotes FZD5 translation.

Promotes HCC cell proliferation and metastasis via β-catenin pathway.

[84]

YTHDF2

HCC

Promotes lncAY expression.

Promotes HCC cell proliferation and migration via β-catenin pathway.

[85]

YTHDF2

LC

Promotes AXIN1 decay.

Promotes LC cell proliferation and metastasis via β-catenin pathway.

[86]

  1. Abbreviations: CC cervical cancer, CRC colorectal cancer, EC esophageal cancer, GC gastric cancer, HCC hepatocellular carcinoma, LC lung cancer, NPC nasopharyngeal cancer